Common Contracts
2 similar Exclusive License Agreement contracts by Oxygen Biotherapeutics, Inc.
EX-10.1 2 dex101.htm LICENSE AGREEMENT EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 5th, 2020 • Virginia
THIS AGREEMENT is made and entered into this 21st day of May, 2008, by and between: SYNTHETIC BLOOD INTERNATIONAL, INC. (hereinafter referred to as the “LICENSEE”) with its principal place of business at 3189 Airway Avenue Bldg. C, Costa Mesa, CA 92626, and VIRGINIA COMMONWEALTH UNIVERSITY INTELLECTUAL PROPERTY FOUNDATION (hereinafter referred to as the “LICENSOR”), and with its principal place of operation at Virginia Commonwealth University, 800 E. Leigh Street, Suite 113, Richmond, Virginia 23298-0568, United States of America.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • September 22nd, 2008 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • Virginia
THIS AGREEMENT is made and entered into this 21st day of May, 2008, by and between: SYNTHETIC BLOOD INTERNATIONAL, INC. (hereinafter referred to as the “LICENSEE”) with its principal place of business at 3189 Airway Avenue Bldg. C, Costa Mesa, CA 92626, and VIRGINIA COMMONWEALTH UNIVERSITY INTELLECTUAL PROPERTY FOUNDATION (hereinafter referred to as the “LICENSOR”), and with its principal place of operation at Virginia Commonwealth University, 800 E. Leigh Street, Suite 113, Richmond, Virginia 23298-0568, United States of America.
